Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.64% | 21.56% | 33.35% | -47.48% | -38.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -76.75% | -20.98% | 45.21% | 216.38% | 5.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 76.41% | -- | -- | -- |
| Total Current Assets | 37.23% | 22.71% | 34.04% | -42.70% | -35.87% |
|
|
|||||
| Total Current Assets | 37.23% | 22.71% | 34.04% | -42.70% | -35.87% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -23.08% | -21.82% | -20.69% | -19.67% | -18.75% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 34.30% | 21.13% | 29.80% | -43.60% | -36.59% |
|
|
|||||
| Total Accounts Payable | 255.90% | 175.76% | 39.36% | 735.89% | 6.59% |
| Total Accrued Expenses | 1.39% | -17.77% | 37.74% | 24.62% | 13.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 52.47% | 10.10% | 32.67% | 65.95% | 9.74% |
|
|
|||||
| Total Current Liabilities | 52.47% | 10.10% | 32.67% | 65.95% | 9.74% |
| Long-Term Debt | -29.65% | -27.60% | -25.82% | -24.26% | -22.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.34% | -1.56% | 11.78% | 28.43% | -3.27% |
|
|
|||||
| Common Stock & APIC | 30.74% | 30.56% | 30.64% | 12.20% | 12.49% |
| Retained Earnings | -29.78% | -28.81% | -28.65% | -26.05% | -24.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 54.14% | 48.05% | 42.53% | -122.32% | -65.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.14% | 48.05% | 42.53% | -122.32% | -65.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.14% | 48.05% | 42.53% | -122.32% | -65.88% |
|
|
|||||